1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Topics

Showing 234 results.

Thumbnail for Population-Level Multiple Myeloma Mortality Trends in the BCMA Era: Age-Specific Racial and Regional Disparities in the United States, 2018-2024 (CDC WONDER Analysis)

MM - 390

Population-Level Multiple Myeloma Mortality Trends in the BCMA Era: Age-Specific Racial and Regional Disparities in the United States, 2018-2024 (CDC WONDER Analysis)

Tapan Giri

Poster Presenter: Tapan Giri

MM - 423

Assessment of the serum level of soluble CD147 in patients with multiple myeloma

Heba Hafez

Poster Presenter: Heba Hafez

MM - 442

An Actionability Score for BCMA-, GPRC5D-, and CD38-targeted therapy selection in multiple myeloma

Tamara Laskowski

Poster Presenter: Tamara Laskowski

$Thumbnail for Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome With Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Three-Target Systematic Review With Trial Versus Real-World Stratification$

MM - 445

Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome With Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Three-Target Systematic Review With Trial Versus Real-World Stratification

P Aravind Sai Reddy

Poster Presenter: P Aravind Sai Reddy

Thumbnail for When Immunotherapy Turns Against Immunity: Progressive Multifocal Leukoencephalopathy under Teclistamab in Lambda Light Chain Myeloma

MM - 451

When Immunotherapy Turns Against Immunity: Progressive Multifocal Leukoencephalopathy under Teclistamab in Lambda Light Chain Myeloma

Nour Haidar

Poster Presenter: Nour Haidar

$Thumbnail for Durability of Response, Mechanisms of Resistance, and Retreatment Outcomes Following CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review$

MM - 453

Durability of Response, Mechanisms of Resistance, and Retreatment Outcomes Following CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Systematic Review

Mahboob Younus Shaik

Poster Presenter: Mahboob Younus Shaik

Thumbnail for Rising Terminal Nutritional-Frailty Vulnerability Despite Declining Overall Multiple Myeloma Mortality: National Trends, Co-Occurring Vulnerability Markers, Place-of-Death Patterns, and Disparities in the United States

MM - 455

Rising Terminal Nutritional-Frailty Vulnerability Despite Declining Overall Multiple Myeloma Mortality: National Trends, Co-Occurring Vulnerability Markers, Place-of-Death Patterns, and Disparities in the United States

Ayse Gul Korkmaz

Poster Presenter: Ayse Gul Korkmaz

$Thumbnail for Secondary Primary Malignancies Associated With BCMA-Directed Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Pharmacovigilance Analysis$

MM - 458

Secondary Primary Malignancies Associated With BCMA-Directed Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A FAERS Pharmacovigilance Analysis

Carmel Awadallah

Poster Presenter: Carmel Awadallah

$Thumbnail for From BCMA to GPRC5D: Sequencing T-Cell Redirecting Therapies in Relapsed/Refractory Multiple Myeloma$

MM - 461

From BCMA to GPRC5D: Sequencing T-Cell Redirecting Therapies in Relapsed/Refractory Multiple Myeloma

Sameer Bhimani

Poster Presenter: Sameer Bhimani